JP Morgan Chase & Co - Vivoryon Therapeutics N.V. - Halle
Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.
Date of transaction
19 feb 2024
Person obliged to notify
JP Morgan Chase & Co
Issuing institution
Vivoryon Therapeutics N.V.
Place of residence
Halle
Distribution in numbers
| Type of share | Number of shares | Number of voting rights | Capital interest | Voting rights | Manner of disposal | Settlement |
|---|---|---|---|---|---|---|
| Type of shareEquity Swap | Number of shares19.781,00 | Number of voting rights19.781,00 | Capital interestPotentieel | Voting rightsPotentieel | Manner of disposalMiddellijk (J.P. Morgan Securities plc) | Settlement |
| Type of shareGewoon aandeel | Number of shares687.858,00 | Number of voting rights687.858,00 | Capital interestReëel | Voting rightsReëel | Manner of disposalMiddellijk (J.P. Morgan Securities LLC) | Settlement |
| Type of shareGewoon aandeel | Number of shares70.324,00 | Number of voting rights70.324,00 | Capital interestReëel | Voting rightsReëel | Manner of disposalMiddellijk (J.P. Morgan Securities plc) | Settlement |
Distribution in percentages
| Type | Total holding | Directly real | Directly potential | Indirectly real | Indirectly potential |
|---|---|---|---|---|---|
| TypeKapitaalbelang | Total holding2,98 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real2,91 % | Indirectly potential0,08 % |
| TypeStemrecht | Total holding2,98 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real2,91 % | Indirectly potential0,08 % |
Date last update: 19 March 2026